A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult Participants

Clinical trial NCT07756645 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07756645
Sponsor: AbbVie
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2026-09-22
Primary completion: 2029-12-01
Enrollment: 940

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.